Provided by Tiger Fintech (Singapore) Pte. Ltd.

Orchestra BioMed

3.31
+0.26008.52%
Post-market: 3.310.00000.00%16:04 EDT
Volume:289.99K
Turnover:944.61K
Market Cap:126.81M
PE:-1.87
High:3.35
Open:3.10
Low:3.06
Close:3.05
Loading ...
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2025

Major Issues Report

Form 8-K - Current report
Apr 01, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Feb 20, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 05, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 07, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]